Literature DB >> 21491444

Water-in-oil-in-water double emulsions: an excellent delivery system for improving the oral bioavailability of pidotimod in rats.

Xiaole Qi1, Lishuang Wang, Jiabi Zhu.   

Abstract

The aims of this study were to prepare fine pidotimod-containing water-in-oil-in-water (W/O/W) double emulsions and to investigate the possibility of those emulsions as a delivery system for promoting the oral bioavailability of pidotimod. A modified two-step emulsification procedure was applied to prepare the double emulsions using medium-chain triglyceride as the oil phase, Tween 80 as the hydrophilic emulsifier, and Span 80 alone or in combination with different amount of phospholipids as the lipophilic emulsifiers. A fine W/O/W emulsion, with the encapsulation efficiency of 82 ± 3.4%, mean oil-droplet diameter of 3.93 ± 0.25 μm, and viscosity of 36.4 ± 0.93 mPa · s at 25 °C and 300 s(-1), was stable for 1 month at 4 °C. In addition, the oral bioavailability of pidotimod in rats, after intragastric administration of W/O/W double emulsions, was significantly higher than that of pidotimod control solution. Moreover, the maximum uptake time was significantly prolonged, suggesting an extra absorption pathway for W/O/W emulsions: a lymphatic circulation pathway. Those results demonstrated that W/O/W emulsions could become a potential formulation for improving the oral bioavailability of poorly absorbable drugs and suggested an important technology platform for the oral administration of peptide and peptidomimetic drugs.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21491444     DOI: 10.1002/jps.22443

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  The detailed analysis of the changes of murine dendritic cells (DCs) induced by thymic peptide: pidotimod(PTD).

Authors:  Xiaofang Hu; Wei Zhang; Lu Wang; Nan Wan; Bing Wang; Weiwei Li; Hui Hua; Xu Hu; Fengping Shan
Journal:  Hum Vaccin Immunother       Date:  2012-08-06       Impact factor: 3.452

2.  Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.

Authors:  Patrícia Severino; Tatiana Andreani; Ana Sofia Macedo; Joana F Fangueiro; Maria Helena A Santana; Amélia M Silva; Eliana B Souto
Journal:  J Drug Deliv       Date:  2011-11-24

3.  Pidotimod: the state of art.

Authors:  Beatrice E Ferrario; Silvia Garuti; Fulvio Braido; Giorgio W Canonica
Journal:  Clin Mol Allergy       Date:  2015-05-21

4.  Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies.

Authors:  Liang-Zhong Lv; Chen-Qi Tong; Qing Lv; Xin-Jiang Tang; Li-Ming Li; Qing-Xia Fang; Jia Yu; Min Han; Jian-Qing Gao
Journal:  Int J Nanomedicine       Date:  2012-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.